Sponsors
1st Latin American Peptide Congress
SPONSORS
OPEN EXPLORATION
An academic publisher of open access, peer-reviewed online journals that produces trusted content, disseminates significant works, and facilitates the open exchange of insights and information across scientific fields.
OPEN EXPLORATION
SUBMIT ONLINE
About the Special lssue
Peptide science occupies a central role in modern drug research and development, emerging as one of the most dynamic and integrative fields. From therapeutic discovery to target engagement and delivery strategies, peptides continue to reveal unprecedented potential for addressing unmet medical needs. This special issue aims to highlight cutting-edge advances within the drug discovery community, fostering a global exchange of ideas that accelerates scientific and therapeutic progress.
Today, peptide-based drug discovery benefits from breakthroughs in solid-phase synthesis, computational design, structural characterization, and high-throughput screening. These tools have enabled the creation of novel peptide analogues, enantiomeric variants, macrocyclic scaffolds, and bioactive sequences with enhanced pharmacological properties, including potency, selectivity, and stability. At the same time, interdisciplinary approaches are reshaping peptide applications in drug development, with a focus on human health, and immunomodulation. By integrating chemistry, biology, pharmacology, and data-driven methods, researchers are uncovering new mechanisms of action, redefining structure–function relationships, and expanding the accessibility of previously unattainable therapeutic peptide candidates.
This special issue welcomes contributions from all geographical regions and sectors, with a focus on innovative strategies, emerging methodologies, and translational potential towards clinical application. We particularly encourage studies that highlight collaborative efforts, novel synthetic approaches, peptide-membrane interactions in the context of drug targeting and delivery, therapeutic explorations for various diseases, and pharmacological studies. By bringing together global expertise, this issue seeks to expand the horizons of peptide-based drug discovery and inspire new directions for future therapeutic development.
CSBI
CSBio Instrumentation designs and manufactures custom peptide and oligonucleotide synthesizers, proudly serving the peptide community for over 30 years. Their systems have been refined into the flexible, reliable, and cost-effective solutions trusted by researchers and manufacturers worldwide. CSBio synthesizers are used in leading universities, biotech companies, and pharmaceutical laboratories around the world for rapid peptide production, process development, and commercial-scale manufacturing. CSBio synthesizers range in reaction vessel size from 6mL to 1000L.
If a character limit is required: For 30 years, CSBio has been delivering custom peptide synthesizers that range from 6mL to 1000L reaction vessels. Trusted by top universities, biotech, and pharmaceutical labs around the world for rapid peptide production, process development, and commercial manufacturing.
Ingenerías 2030
Consortium of Engineering Faculties, formed by the Universidad Autónoma de Chile and the Universidad de Magallanes. The UA–UMAG consortium emerges from a shared commitment to transform their Engineering Faculties into institutions distinguished by the training of world-class engineers. It emphasizes the development of strong competencies in innovation and science-based technological entrepreneurship, with a focus on the energy sector and environmental sustainability.
HES
Our contribution is to provide comprehensive solutions to your needs, supported by our represented brands—leading companies in the global market for equipment and instruments.
Additionally, we can source other equipment, spare parts, or supplies from international markets according to your requirements, offering highly competitive delivery times and prices.
Our company is ISO 9001:2015 certified, reflecting our commitment to continuous improvement systems and our strong focus on service quality and process excellence, all aimed at meeting your needs.
Arquimed
ARQUIMED provides comprehensive solutions for the Health, Education, and Industry sectors throughout the country. World-class leaders have placed their trust in us to represent and distribute their products in Chile. Our company ranks among the ten most important suppliers to the Chilean government, participating in around 10,000 public tenders each year.
We offer nationwide technical service, with more than 100 specialized technicians who are factory-trained and certified under strict quality standards. We also have some of the most complete showrooms in Latin America, featuring permanent exhibitions of a wide range of products from leading global companies.
Our Distribution Center, with 8,000 m² of warehouse space, manages over 2,500 monthly shipments and ensures efficient delivery across the entire national territory.
Quantux
We strive to offer our clients reliable and long-lasting solutions for research, development, routine daily analysis, and quality control across laboratories nationwide. We understand that quality is essential, and for this reason, we aim to stand out by addressing our clients’ needs based on the principle of Excellence and by fostering long-term relationships.
Galenica
Galenica is a leading IVD player in Chile focus on Clinical Laboratory, Molecular Biology, Quality Control, Blood Banking, Biotechnology, Medicine and Laboratory Information System (LIS) segments. Galénica imports, distributes and commercialize IVD reagents, consumables, instruments, and equipment along with an excellent after-sales service. Galenica focus on providing high quality and high technology products and solutions. The Company’s offerings include consulting, training and a dedicated after-sales service that translates into added value for its customers. Galenica’s main customers include public and private hospitals, blood banks, clinical laboratories, universities, medical and research centers. Galenica has been in operation for more than 37 years in Chile and has recently expanded into Peru.
Biomx
We are a clinical laboratory focused on improving medical diagnosis through innovation in the clinical analysis of tests required by the community. We have modern infrastructure and state-of-the-art technology for sample processing and analysis, which allow us to guarantee excellent, accurate results with short turnaround times.
What sets us apart as a laboratory is that we are pioneers in implementing various Molecular Biology tests in the Fifth Region, making them accessible to the entire community. In addition, we offer traditional tests in hematology, chemistry, hormones, immunology, parasitology, bacteriology, and urinalysis.
ACCIDS
Since 2013, ACCDiS has brought together leading experts in biomedicine, epidemiology, public health, and clinical medicine to investigate the most relevant chronic diseases in Chile: cancer and cardiovascular diseases. Our transdisciplinary approach allows us to generate knowledge that directly impacts public policy, prevention, and treatment.
After 10 years of operation, ACCDiS is recognized by Chilean society as a high-profile research center for the study of cancer and cardiovascular diseases, enabling the participation of scientific experts in the development of public health policies, national interest topics, and the dissemination of science within the Chilean community.
CEM
CEM was founded in 1978 by its current CEO, Dr. Michael J. Collins. For over 40 years, the company has designed and developed laboratory instrumentation and scientific methods (including both microwave-based and non-microwave technologies) that are used by major companies, prestigious research institutes, and universities around the world. It is a private company with global headquarters outside Charlotte, North Carolina, and additional offices in England, Germany, Japan, France, Italy, Singapore, and Ireland. Its major products provide unique solutions for compositional analysis of food and chemical samples, acid digestion for elemental analysis, and the chemical synthesis of peptides and small molecules.
Makerspace
We are a creative, technological, and collaborative space hosted at PUCV and open to the entire Valparaíso region. We promote the maker philosophy of “do it yourself,” spreading knowledge and democratizing technology. We operate as a collective brain, and our goal is to inspire both those who are already part of our community and those who will join, empowering them to transform the future through innovation with a focus on prototyping.
Science UP
ScienceUp is a consortium formed by UCN, PUCV, and USACH, created after winning CORFO’s Science and Innovation for 2030 project. Its goal is to transform the faculties of science through a strategic plan that strengthens undergraduate and graduate programs, improving their connection with society and the productive sector.
In its first stage (2018–2020), the consortium carried out technological tours in the U.S. and Europe to compare international models and define its action plan. In the second stage (2021–2026), it seeks to boost R&D, technology transfer, innovation, and science-based entrepreneurship, involving faculty, researchers, and students.
The consortium aims to train highly competent professionals capable of conducting applied research, driving technological developments, and innovating from the sciences.
Ines Género
The InES Gender Project of the Pontificia Universidad Católica de Valparaíso seeks to reduce gender gaps in the fields of research, development, and innovation through the implementation of a Development Plan that promotes gender equity within Chile’s national Science, Technology, Knowledge, and Innovation (CTCI) policy at PUCV. The project is funded by the Chilean National Agency for Research and Development and is overseen by the Vice-Rectory for Research, Creation, and Innovation.
The project aims to position the Pontificia Universidad Católica de Valparaíso as a national leader in promoting gender equity in CTCI through strategies that are sustainable over time.